Griseofulvin
NDC 42794-012, Griseofulvin, tablet, from Sigmapharm Laboratories, LLC.
- Product NDC
- 42794-012
- Status
- Listed
- Labeler
- Sigmapharm Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202482
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42794-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN500 mg/1
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42794-012-08 | 42794001208 | 30 TABLET in 1 BOTTLE (42794-012-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5bafb97f-621b-4b96-a787-68e0bb5c8637NADAC price for package 42794001208
GET /v1/drugs/nadac/42794001208
Use it
Look up 42794-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42794-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42794-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.